Clinical trials critical to vaccine self-sufficiency — Prez

By Linda Naa Deide Aryeetey, GNA

Accra, Nov. 18, GNA – President John Dramani Mahama has urged Ghanaians to participate in clinical trials, saying public confidence in scientific research is essential for the country’s efforts to develop and manufacture vaccines locally.

He said public support for scientific research would be critical to achieving vaccine self-sufficiency and strengthening Ghana’s preparedness for future disease outbreaks.

The President made the call on Wednesday when he commissioned the Vaccine Research and Development Laboratory and the Human Identification Laboratory at the Noguchi Memorial Institute for Medical Research of the University of Ghana in Accra.

“Ghana’s ambition to achieve vaccine self-sufficiency would require public cooperation and confidence in scientific research, particularly clinical trials, which are critical to establishing the safety and effectiveness of vaccines before they were made available for wider use,” he said.

President Mahama recalled that plans to conduct clinical trials for an Ebola vaccine at the University of Health and Allied Sciences in 2015 were halted following public concerns and misinformation, leading to the relocation of the research to another country.

He said Ghana could not develop its own vaccines without the willingness of citizens to participate in properly conducted clinical research.

The President said Ghana was among five African countries using messenger RNA (mRNA) technology in vaccine research and development, adding that the National Vaccine Institute was pursuing international partnerships, including discussions on cancer vaccine research.

He said the new laboratory would provide national capacity for vaccine research, while five Ghanaian scientists trained in mRNA technology were expected to support local capacity building.

President Mahama said the facility was particularly important as Africa continued to face threats from diseases such as Mpox, Lassa fever, Ebola and Marburg virus disease.

He said the COVID-19 pandemic exposed weaknesses in global vaccine supply chains and demonstrated the need for African countries to strengthen domestic research, manufacturing and production capacity.

On the Human Identification Laboratory, the President said it was established following the August 6, 2025, helicopter crash, when tissue samples had to be sent to South Africa for DNA analysis.

He said the absence of local DNA testing capacity delayed identification efforts and prolonged the wait for affected families.

“It was a day of shame for Ghana that we could not carry out our own DNA analysis in-country. That will be a thing of the past,” he said.

President Mahama said the facility would support criminal investigations, including rape and murder cases, as well as paternity and other identity-related investigations.

He said the two laboratories would strengthen Ghana’s capacity to conduct vaccine research and forensic investigations locally while reducing reliance on external laboratories.

GNA
Edited by Kenneth Sackey
Reporter:Linda Naa Deide Aryeetey
Email: [email protected]